Benign Prostatic Hyperplasia Treatment Market to be worth Nearly US$ 12 Billion by 2027- TMR Albany, New York, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report on the benign prostatic hyperplasia treatment market for the forecast period of...

Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments: Pharma Proff NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- According to a new research report titled “Benign Prostatic Hyperplasia (BPH) Therapeutics – Pipeline Analysis 2019, Clinical Trials and Results, Patents,...

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market to expand at a CAGR of 4.6% by 2028- Future Market Insights VALLEY COTTAGE, N.Y. , March 12, 2019 (GLOBE NEWSWIRE) -- The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028,...

US Benign Prostatic Hyperplasia (BPH) Procedures to Grow at a CAGR of 4.2% by 2023: P&S Market Research NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- According to new market research report titled “US Benign Prostatic Hyperplasia (BPH) Procedures by Type (Green Light Lasers, Holmium Lasers, Thulium...